Viewing StudyNCT00400803



Ignite Creation Date: 2024-05-05 @ 5:10 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00400803
Status: COMPLETED
Last Update Posted: 2017-12-28
First Post: 2006-11-15

Brief Title: Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIbIV Non-small Cell Lung Cancer
Sponsor:
Organization: Masonic Cancer Center University of Minnesota